Post by
Johnmeco on Feb 04, 2022 11:47am
Email from Dr. Friesen
This is copy from yahoo Isaac's post From Dr. Friesen Both Pemetrexed and Bortezomib are scheduled for approval this summer. Waverley Pharma is presently working with GPOs and other buying groups to get contracts for both products this summer. Waverley Pharma has won some contracts in the UK and bidding on a number in the EU. So far the contracts have been relatively small and very low prices. Waverley Pharmas main interest has always been the USA, which has a much better pricing structure for generics and much higher volumes. As part of our negotiating, Reliance Life Sciences asked us to take on the some UK and EU countries. My focus is to grow the company and use the profits to acquire and develop other products. We have negotiated on a number but have been conserving cash to get to profitability. I appreciate your interest and am hopefully of significant activities to share with the market this summer.